Directorio de personas
José Vicente Hervás Garcia

José Vicente Hervás Garcia


Grupos

Publicaciones

  • Gil-Sanchez A; Canudes M; Valcheva P; Nogueras L; González-Mingot C; Hervás JV; Peralta S; Solana MJ; Brieva L

    Effects of vortioxetine on cognition and fatigue in patients with multiple sclerosis and depression: a case series study.

    CNS & Neurological Disorders-Drug Targets 23 395-401. .

    [doi:10.2174/1871527322666230321093133]

  • Martín-Aguilar L.; Presas-Rodriguez S.; Rovira À.; Capellades J.; Massuet-Vilamajó A.; Ramió-Torrentà L.; Tintoré M.; Brieva-Ruiz L.; Moral E.; Cano-Orgaz A.; Blanco Y.; Batlle-Nadal J.; Carmona O.; Gea M.; Hervás-García J.V.; Ramo-Tello C.

    Gadolinium-enhanced brain lesions in multiple sclerosis relapse

    NEUROLOGIA 37 557-563. .

    [doi:10.1016/j.nrl.2021.10.005]

  • Gonzalo, H; Nogueras, L; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Martin-Gari, M; Canudes, M; Peralta, S; Solana, MJ; Pamplona, R; Portero-Otin, M; Boada, J; Serrano JCE; Brieva, L

    Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients

    Frontiers in Neuroscience 13 938-938. .

    [doi:10.3389/fnins.2019.00938]

  • Nogueras, L; Gonzalo, H; Jove, M; Sol, J; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Solana, MJ; Peralta, S; Pamplona, R; Brieva, L

    Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis

    SCIENTIFIC REPORTS 9 11313-11313. .

    [doi:10.1038/s41598-019-47906-x]

  • Hervas-Garcia, JV; Pagani-Cassara, F

    Chronic relapsing inflammatory optic neuropathy: a literature review

    REVISTA DE NEUROLOGIA 68 524-530. .

    [doi:10.33588/rn.6812.2018261]

  • Gil, A; Pardinas, B; Hervas, V; Lecina, J; Solana, MJ; Peralta, S; Forne, C; Gonzalez, C; Gonzalo, H; Nogueras, L; Brieva, L

    Pilot Study of Telemedicine in multiple sclerosis to evaluate the effectiveness of a telecommunication system for the detection of the clinical activity of the disease in the number of relapses with respect to the standard clinical practice. TELEM

    MULTIPLE SCLEROSIS JOURNAL 24 795-796. .

  • Ramo-Tello, C.; Hervas-Garcia, J-V; Presas-Rodriguez, S.; Capallades, J.; Ramio-Torrenta, L.; Brieva, L.; Batlle, J.; Moral, E.; Blanco, Y.; Cano, A.; Torres, F.

    A multicentre, randomized, double-blind, non-inferiority clinical trial to compare the clinical and radiological efficacy of 625 mg versus 1250 mg of oral methylprednisolone in patients with relapse of multiple sclerosis: the Oral-CORTEM trial

    MULTIPLE SCLEROSIS JOURNAL 23 403-403. .

  • Nogueras Penabad, L.; Gil Sanchez, A.; Hervas, J. V.; Gonzalez, C.; Marti, M.; Canudes, M.; Peralta, S.; Moga, M. J.; Boada, J.; Pamplona, R.; Portero, M.; Brieva, L.; Gonzalo, H.

    Mitochondrial dysfunction in peripheral blood mononuclear cells from multiple sclerosis patients

    MULTIPLE SCLEROSIS JOURNAL 23 509-509. .

  • Martin-Aguilar, L.; Presas-Rodriguez, S.; Hervas-Garcia, J. V.; Massuet-Vilamajo, A.; Grau-Lopez, L.; Ramo-Tello, C.

    Relationship between clinical manifestation of MS relapse and Gadolinium enhancing lesions in brain MRI

    MULTIPLE SCLEROSIS JOURNAL 23 545-546. .